Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

REduced Frequency ImmuNE Checkpoint Inhibition in Cancers (REFINE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04913025
Recruitment Status : Not yet recruiting
First Posted : June 4, 2021
Last Update Posted : October 15, 2021
Sponsor:
Collaborator:
JP Moulton Charitable Trust
Information provided by (Responsible Party):
University College, London

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Not yet recruiting
Estimated Primary Completion Date : April 2025
Estimated Study Completion Date : April 2025